Shanghai Shen Lian Biomedical Corporation (SHSE: 688098)
Health Care · Pharmaceuticals · CN
CN¥8.25
-4.18% today · -43.1% 1Y
Shanghai Shen Lian Biomedical Corporation (SHSE: 688098) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $499.76M and employs 375 people.
Over the last twelve months the share price has lost 43.1%, trading between 7.29 and 15.00.
Tweenvest scores Shanghai Shen Lian Biomedical Corporation across four factors: quality 73/100, value 35/100, growth 0/100. Its strongest factor is quality.
688098 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $499.76M
- Revenue (TTM)
- $39.45M
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- 0.55
- 52-week high
- CN¥15.00
- 52-week low
- CN¥7.29
- Avg volume (3M)
- —
- Shares outstanding
- 407.23M
- Employees
- 375
- Next earnings
- —
About Shanghai Shen Lian Biomedical Corporation
Shanghai Shen Lian Biomedical Corporation operates within China's animal health industry, specializing in the entire lifecycle of veterinary biological products, from initial research and development to manufacturing and sales. A primary focus for the company is the creation of advanced synthetic peptide vaccines, specifically engineered to combat foot-and-mouth disease. This enterprise was established in 2001 and is based in Shanghai, China.
- ISIN
- CNE100003P17
- Founded
- 2001
- Listed since
- Oct 28, 2019
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,205.00 | -2.32% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.60 | -0.93% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.84 | -1.67% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.90 | -1.04% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.60 | -1.73% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.24 | -1.16% |
Figures last refreshed Aug 18, 2026.